- Krispy Kreme’s CEO defended the company against backlash it faced after offering customers who get the COVID-19 vaccine a free donut each day for the rest of the year.
- Critics of the promotions cited the obesity problem in the U.S., the health effects of eating a donut every day, and the fact that people who are obese face a higher risk of complications and death from coronavirus.
- “We’re a sweet treat company, [and] if folks don’t want to visit a donut shop, they don’t have to… if they decide to combine a Krispy Kreme pickup (for) a donut, they can. That’s how we look at it… generosity,” CEO Mike Tattersfield told Yahoo Finance Live.
- Krispy Kreme previously explained that it isn’t encouraging people to eat donuts daily but is just making the offer available to people every day because not every group is eligible to get vaccinated yet.
Krispy Kreme CEO Addresses Backlash
Krispy Kreme’s CEO has responded to critics who pushed back against its free donut promotion that hopes to encourage more COVID-19 vaccinations.
“We’re a sweet treat company, [and] if folks don’t want to visit a donut shop, they don’t have to,” Krispy Kreme CEO Mike Tattersfield told Yahoo Finance Live on Friday.
“Folks that want to get a vaccine, if they decide to combine a Krispy Kreme pickup [for] a donut, they can. That’s how we look at it … generosity,” he added.
Tattersfield also talked about a previous promotion from last year which offered healthcare workers free donuts.
“I drop off a lot of doughnuts to the healthcare system,” he explained. “They’re very appreciative, given the days that they have to work. People are always looking for a little sweet treat break. It’s OK.”
Reactions To Promotion
Tattersfield’s comments hit back at outrage that appeared earlier this month when the donut chain announced that it was offering customers who showed proof of their COVID-19 vaccinations a free donut each day for the rest of the year.
Some applauded the company when it made this announcement, saying it was a nice incentive to encourage vaccinations. Still, others made jokes and criticized the promotion, citing the country’s obesity problem and the health effects of eating a donut every day.
Many also noted that patients who are obese face a higher risk of complications and death from coronavirus.
“Krispy Kreme offering free doughnuts for getting vaccinated is like Marlboro offering free cigarettes for getting a flu shot.” Dr. Eugene Gu wrote on social media.
Despite the criticism, many have defended the company by arguing that most people are unlikely to take advantage of the promotion every single day. Others found the outrage odd and distracting from the greater goal of getting through the pandemic.
The CEO’s remarks mirror a mirror a statement Krispy Kreme gave to outlets last week.
“Like many sweet treats, Krispy Kreme Doughnuts are an occasional indulgence best enjoyed in moderation. And we know that’s how most of our guests enjoy our doughnuts,” the company said.
“We’re certainly not asking people to get a free Original Glazed doughnut every day, we’re just making it available through the end of the year, especially given that not every group is eligible to get vaccinated yet.”
See what others are saying: (Insider) (Yahoo Finance) (USA Today)
Facebook Is Reviewing More Than 2,200 Hours of Footage for Next-Gen AI
The project, which could prove to be revolutionary, is already raising some big privacy concerns.
Facebook’s Next-Gen AI
Facebook announced Thursday that it has captured more than 2,200 hours of first-person video that it will use to train next-gen AI models.
The company said it aims to make the AI, called Ego4D, capable of understanding and identifying both real and virtual objects through a first-person perspective using smart glasses or VR headsets. In effect, that could potentially help users do everything from remembering where they placed forgotten items to recording others in secret.
Facebook listed five key scenarios the project aims to tackle and gave real-world examples of how each may look for people who will eventually use the AI.
- “What happened when?” With that scenario, Facebook gave the example, “Where did I leave my keys?”
- “What am I likely to do next?” There, Facebook gave the example, “Wait, you’ve already added salt to this recipe.”
- “What am I doing?” For example, “What was the main topic during class?”
- “Who said what when?” For example, “What was the main topic during class?”
- “Who is interacting with whom?” For example, “Help me better hear the person talking to me at this noisy restaurant.”
Facebook said the amount of footage it has collected is 20 times greater than any other data set used by the company.
In the wake of recent controversy surrounding Facebook, it’s important to note that the footage wasn’t reaped from users. Instead, the company said it, and 13 university partners, compiled the footage from more than 700 participants around the world.
Still, that hasn’t alleviated all privacy concerns.
In an article titled, “Facebook is researching AI systems that see, hear, and remember everything you do,” The Verge writer James Vincent said that although the project’s guidelines seem practical, “the company’s interest in this area will worry many.”
Vincent pointe out that the AI announcement doesn’t mention anything in the way of privacy or removing data for people who may not want to be recorded.
A Facebook spokesperson later assured Vincent that privacy safeguards will be introduced to the public in the future.
“For example, before AR glasses can enhance someone’s voice, there could be a protocol in place that they follow to ask someone else’s glasses for permission, or they could limit the range of the device so it can only pick up sounds from the people with whom I am already having a conversation or who are in my immediate vicinity,” the spokesperson said.
Among positive reception, some believe the tech could be revolutionary for helping people around the house, as well as for teaching robots to more rapidly learn about their surroundings.
FDA Issues Its First E-Cigarette Authorization Ever
The authorization only applies to tobacco-flavored products, as the FDA simultaneously rejected several sweet and fruit-flavored e-cigarette cartridges.
FDA Approves E-Cigarette
The U.S. Food and Drug Administration approved an e-cigarette pen sold under the brand name Vuse on Tuesday, as well as two tobacco-flavored cartridges that can be used with the pen.
This marks the first time the FDA has ever authorized the use of vaping products. In a news release, the agency said it made the decision because “the authorized products’ aerosols are significantly less toxic than combusted cigarettes based on available data.”
“The manufacturer’s data demonstrates its tobacco-flavored products could benefit addicted adult smokers who switch to these products — either completely or with a significant reduction in cigarette consumption — by reducing their exposure to harmful chemicals,” the agency added.
The company that owns Vuse, R.J. Reynolds Vapor Company, also submitted several sweet and fruit-flavored pods for review; however, those were all rejected. While the FDA did not specify which flavors it rejected, it did note that it has yet to make a decision on whether to allow menthol-flavored e-cigarettes, including ones sold under Vuse.
FDA Is Reviewing All Vape Products Still on the Market
In January 2020, the FDA banned pre-filled pods with sweet and fruity flavors from being sold. While other e-cigarette related products, including some forms of flavored vapes, were allowed to stay on the market for the time being, they were only able to do so if they were submitted for FDA review.
The FDA’s primary issue with fruity cartridges stems from statistics showing that those pods more easily hook new smokers, particularly underage smokers.
In fact, in its approval of the Vuse products, the FDA said it only authorized them because it “determined that the potential benefit to smokers who switch completely or significantly reduce their cigarette use, would outweigh the risk to youth, provided the applicant follows post-marketing requirements aimed at reducing youth exposure and access to the products.”
While some have cheered the FDA’s decision, not everyone was enthusiastic. Many critics cited a joint FDA-CDC study in which nearly 11% of teens who said they vape also indicated regularly using Vuse products.
See what others are saying: (Business Insider) (Wall Street Journal) (The Washington Post)
Kaiser Permanente Health Workers Vote To Authorize Strike Over Pay, Staffing, and Safety
The vote could inspire unioned Kaiser workers in other states to eventually approve strikes of their own.
Workers Approve Strike
Over 24,000 unioned nurses and other healthcare workers at Kaiser Permanente hospitals voted Monday to authorize strikes against the company in California and Oregon.
The tens of thousands of workers who cast a ballot make up 86% of the Kaiser-based healthcare professionals represented by either the United Nurses Associations of California/Union of Health Care Professionals (UNAC/UHCP) or the Oregon Federation of Nurses and Health Professionals. An overwhelming 96% voted to approve the strike.
According to both unions, the list of workers includes nurses, pharmacists, midwives, and physical therapists.
The vote itself does not automatically initiate a strike; rather, it gives the unions the power to call a strike amid stalled contract negotiations between Kaiser and the unions. If the unions ultimately tell their members to begin striking, they will need to give a 10-day warning.
The California and Oregon contracts expired Sep. 30, but several more Kaiser-based union contracts are rapidly approaching their expiration dates as well. That includes contracts for more than 50,000 workers in Colorado, Georgia, Hawaii, Maryland, Virginia, Washington state, and D.C. Notably, the demands from those workers echo many of the demands made by California and Oregon’s union members.
At the center of this potential strike are three issues: staffing problems, safety concerns, and proposed revisions to Kaiser’s payment system. For months, nurses have been publicly complaining about long shifts spurred by the COVID-19 pandemic, staffing shortages, and an over-reliance on contract nurses.
Because of that, they’re seeking to force Kaiser to commit to hiring more staff, as well as boost retention.
But the main catalyst for any looming strikes is pay. According to UNAC/UHCP, Kaiser wants to implement a two-tier payment system, which would decrease earnings by 26% to 39% for employees hired from 2023 onward. On top of that, those new employees would see fewer health protections.
The unions and their members worry such a system could lead to an increased feeling of resentment among workers since they would be paid different rates for performing the same job. They also worry it could exacerbate retention and hiring issues already faced by the hospital system.
Additionally, the workers want to secure 4% raises for each of the next three years, but Kaiser’s currently only willing to give 1%, citing a need to reduce labor costs to remain competitive.